Literature DB >> 20420745

Early changes in right ventricular function and their clinical consequences in childhood and adolescent dilated cardiomyopathy.

Lars Grosse-Wortmann1, Susan L Roche, Shi-Joon Yoo, Mike Seed, Paul Kantor.   

Abstract

The aim of the paper was to investigate the right ventricle in paediatric dilated cardiomyopathy. We examined 11 patients with dilated cardiomyopathy as well as 12 normal paediatric controls. Cardiac magnetic resonance imaging was performed for ventricular size and function. N-terminal pro-brain natriuretic peptide was collected at this time and the results from the most recent echocardiogram and exercise test were reviewed.We found that patients with dilated cardiomyopathy had significantly faster heart rates, that is, 85 versus 65 beats per minute, lower left ventricular ejection fraction, that is, 42 versus 61%, and right ventricular ejection fraction of 44 versus 54%, lower left and right ventricular stroke volumes, that is, 35.5 versus 49.5 millilitres per square metre and 40.9 versus 56.4 millilitres per square metre, respectively, and lower mitral and tricuspid valve inflow e/a wave velocity ratios of 2.02 versus 2.80 and 1.25 versus 2.58, respectively, than the controls. Tricuspid valve annulus velocity, measured by tissue Doppler echocardiography, correlated with right ventricular ejection fraction (r = 0.60, p = 0.05). Right ventricular ejection fraction and indexed right ventricular end-diastolic volume correlated with N-terminal pro-brain natriuretic peptide (r = -0.67, p = 0.03, r = 0.65, p = 0.04, respectively), and right ventricular ejection fraction correlated with the oxygen uptake at the anaerobic threshold (r = 0.67, p = 0.049). Neither left ventricular ejection fraction nor left ventricular volume correlated with N-terminal pro-brain natriuretic peptide or exercise tolerance. The right ventricular function is decreased in the early stages of dilated cardiomyopathy. Right ventricular size and ejection fraction may be important indicators of sub-clinical cardiac failure and we suggest monitoring them routinely in dilated cardiomyopathy.

Entities:  

Mesh:

Year:  2010        PMID: 20420745     DOI: 10.1017/S1047951109990540

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  5 in total

1.  Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.

Authors:  Heiner Latus; Kerstin Gummel; Karin Klingel; Axel Moysich; Markus Khalil; Nona Mazhari; Juergen Bauer; Reinhard Kandolf; Dietmar Schranz; Christian Apitz
Journal:  J Cardiovasc Magn Reson       Date:  2015-05-15       Impact factor: 5.364

2.  Increased left ventricular myocardial extracellular volume is associated with longer cardiopulmonary bypass times, biventricular enlargement and reduced exercise tolerance in children after repair of Tetralogy of Fallot.

Authors:  Eugénie Riesenkampff; Wietske Luining; Mike Seed; Paweena Chungsomprasong; Cedric Manlhiot; Bernadette Elders; Brian W McCrindle; Shi-Joon Yoo; Lars Grosse-Wortmann
Journal:  J Cardiovasc Magn Reson       Date:  2016-10-26       Impact factor: 5.364

3.  Magnetic resonance imaging of the transplanted pediatric heart as a potential predictor of rejection.

Authors:  Steven C Greenway; Frederic Dallaire; Paul F Kantor; Anne I Dipchand; Rajiv R Chaturvedi; Monali Warade; Eugenie Riesenkampff; Shi-Joon Yoo; Lars Grosse-Wortmann
Journal:  World J Transplant       Date:  2016-12-24

4.  Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.

Authors:  Seiko Ide; Eugenie Riesenkampff; David A Chiasson; Anne I Dipchand; Paul F Kantor; Rajiv R Chaturvedi; Shi-Joon Yoo; Lars Grosse-Wortmann
Journal:  J Cardiovasc Magn Reson       Date:  2017-02-01       Impact factor: 5.364

Review 5.  SCMR expert consensus statement for cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease.

Authors:  Adam L Dorfman; Tal Geva; Margaret M Samyn; Gerald Greil; Rajesh Krishnamurthy; Daniel Messroghli; Pierluigi Festa; Aurelio Secinaro; Brian Soriano; Andrew Taylor; Michael D Taylor; René M Botnar; Wyman W Lai
Journal:  J Cardiovasc Magn Reson       Date:  2022-07-21       Impact factor: 6.903

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.